CoChat

Aromatase and 5α-Reductase Inhibition during an Exogenous Testosterone Clamp Unveils Selective Sex Steroid Modulation of Somatostatin and Growth Hormone Secretagogue Actions in Healthy Older Men

Open access
Veldhuis, Johannes D., Mielke, Kristi L., Cosma, Mihaela, Soares-Welch, Cacia, Paulo, Remberto, Miles, John M., Bowers, Cyril Y. · 2009 · The Journal of Clinical Endocrinology & Metabolism
Cited by 42

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

Background: How endogenous testosterone (Te), 5α-dihydrotestosterone (DHT), and estradiol (E2) regulate pulsatile GH secretion is not understood. Hypothesis: Conversion of Te to androgenic (Te→DHT) or estrogenic (Te→E2) products directs GH secretion. Subjects and Location: Healthy older men (N = 42, ages 50–79 yr) participated at an academic medical center. Methods: We inhibited 5α-reduction with dutasteride and aromatization with anastrozole during a pharmacological Te clamp and infused somatostatin (SS), GHRH, GH-releasing peptide-2 (GHRP-2), and l-arginine/GHRH/GHRP-2 (triple stimulus) to modulate GH secretion. Endpoints: Deconvolution-estimated basal and pulsatile GH secretion was assessed. Results: Administration of Te/placebo elevated Te by 2.8-fold, DHT by 2.6-fold, and E2 concentrations by 1.9-fold above placebo/placebo. Te/dutasteride and Te/anastrozole reduced stimulated DHT and E2 by 89 and 86%, respectively. Stepwise forward-selection regression analysis revealed that 1) Te positively determines mean (P = 0.017) and peak (P < 0.001) GH concentrations, basal GH secretion (P = 0.015), and pulsatile GH secretion stimulated by GHRP-2 (P < 0.001); 2) Te and E2 jointly predict GH responses to the triple stimulus (positively for Te, P = 0.006, and negatively for E2, P = 0.031); and 3) DHT correlates positively with pulsatile GH secretion during SS infusion (P = 0.011). These effects persisted when abdominal visceral fat was included in the regression. Conclusion: The present outcomes suggest a tetrapartite model of GH regulation in men, in which systemic concentrations of Te, DHT, and E2 along with abdominal visceral fat determine the selective actions of GH secretagogues and SS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2008-2108

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Research works printed but not linked: 45

  1. Veldhuis, 2006, Somatotropic and gonadotropic axes linkages in infancy, childhood, and the puberty-adult transition., Endocr Rev, 27, 101, 10.1210/er.2005-0006 · DOI · Paper page
  2. Kojima, 2000, Ghrelin is a growth-hormone-releasing acylated peptide from stomach., Nature, 402, 656, 10.1038/45230 · DOI · Paper page
  3. Arvat, 2001, Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone., J Clin Endocrinol Metab, 86, 1169
  4. Bowers, 1999, GH releasing peptides (GHRPs), Kostyo J, Goodman H, eds. Handbook of physiology. New York: Oxford University Press;, 267
  5. Korbonits, 2001, The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumors., J Clin Endocrinol Metab, 86, 881
  6. Pantel, 2006, Loss of constitutive activity of the growth hormone secretagogue receptor in familial short stature., J Clin Invest, 116, 760, 10.1172/JCI25303 · DOI · Paper page
  7. Iranmanesh, 1998, Unequal impact of age, percentage body fat, and serum testosterone concentrations on the somatotrophic, IGF-I, and IGF-binding protein responses to a three-day intravenous growth hormone-releasing hormone pulsatile infusion in men., Eur J Endocrinol, 139, 59, 10.1530/eje.0.1390059 · DOI · Paper page
  8. Veldhuis, 1995, Differential impact of age, sex-steroid hormones, and obesity on basal versus pulsatile growth hormone secretion in men as assessed in an ultrasensitive chemiluminescence assay., J Clin Endocrinol Metab, 80, 3209
  9. Muniyappa, 2007, Long-term testosterone supplementation augments overnight growth hormone secretion in healthy older men, Am J Physiol Endocrinol Metab, 293, E769, 10.1152/ajpendo.00709.2006 · DOI
  10. Veldhuis, 2006, Estradiol potentiates ghrelin-stimulated pulsatile GH secretion in postmenopausal women., J Clin Endocrinol Metab, 91, 3559, 10.1210/jc.2006-0948 · DOI
  11. Veldhuis, 2004, Estradiol supplementation in postmenopausal women doubles rebound-like release of growth hormone (GH) triggered by sequential infusion and withdrawal of somatostatin: evidence that estrogen facilitates endogenous GH-releasing hormone drive., J Clin Endocrinol Metab, 89, 121, 10.1210/jc.2003-031291 · DOI · Paper page
  12. Bray, 2001, Short-term estradiol replacement in postmenopausal women selectively mutes somatostatin’s dose-dependent inhibition of fasting growth hormone secretion., J Clin Endocrinol Metab, 86, 3143
  13. Rigamonti, 2006, Testosterone inhibition of growth hormone release stimulated by a growth hormone secretagogue: studies in the rat and dog., Neuroendocrinology, 84, 115, 10.1159/000096998 · DOI
  14. Veldhuis, 2005, Testosterone supplementation in healthy older men drives GH and IGF-I secretion without potentiating peptidyl secretagogue efficacy., Eur J Endocrinol, 153, 577, 10.1530/eje.1.02001 · DOI · Paper page
  15. Loche, 1997, The growth hormone response to hexarelin in children: reproducibility and effect of sex steroids., J Clin Endocrinol Metab, 82, 861
  16. Fryburg, 1997, Short-term modulation of the androgen milieu alters pulsatile but not exercise or GHRH-stimulated GH secretion in healthy men., J Clin Endocrinol Metab, 82, 3710
  17. Keenan, 1993, Androgen-stimulated pubertal growth: the effects of testosterone and dihydrotestosterone on growth hormone and insulin-like growth factor-I in the treatment of short stature and delayed puberty., J Clin Endocrinol Metab, 76, 996
  18. Paulo, 2008, Gonadal status and body-mass index jointly determine GHRH/GHRP synergy in healthy men., J Clin Endocrinol Metab, 93, 944, 10.1210/jc.2007-1388 · DOI
  19. Kamegai, 2001, Estrogen receptor (ER)α, but not ERβ, gene is expressed in growth hormone-releasing hormone neurons of the male rat hypothalamus., Endocrinology, 142, 538, 10.1210/endo.142.2.7933 · DOI
  20. Yan, 2004, Functional modification of pituitary somatotropes in the aromatase knockout mouse and the effect of estrogen replacement., Endocrinology, 145, 604, 10.1210/en.2003-0646 · DOI
  21. Kimura, 1998, Chronic treatment with estrogen up-regulates expression of sst2 messenger ribonucleic acid (mRNA) but down-regulates expression of sst5 mRNA in rat pituitaries., Endocrinology, 139, 1573, 10.1210/endo.139.4.5952 · DOI · Paper page
  22. Sanford, 2008, Anastrozole: a review of its use in postmenopausal women with early-stage breast cancer., Drugs, 68, 1319, 10.2165/00003495-200868090-00007 · DOI
  23. Keam, 2008, Dutasteride: a review of its use in the management of prostate disorders., Drugs, 68, 463, 10.2165/00003495-200868040-00008 · DOI
  24. Veldhuis, 2005, Distinctive inhibitory mechanisms of age and relative visceral adiposity on GH secretion in pre- and postmenopausal women studied under a hypogonadal clamp., J Clin Endocrinol Metab, 90, 6006, 10.1210/jc.2005-0854 · DOI
  25. Paulo, 2008, Estrogen elevates the peak overnight production rate of acylated ghrelin., J Clin Endocrinol Metab, 93, 4440, 10.1210/jc.2008-0783 · DOI
  26. Cosma, 2008, Pituitary and/or peripheral estrogen-receptor α (ERα) regulates FSH secretion whereas central pathways direct GH and prolactin secretion in postmenopausal women., J Clin Endocrinol Metab, 93, 951, 10.1210/jc.2007-1322 · DOI
  27. Keenan, 2003, Physiological control of pituitary hormone secretory-burst mass, frequency and waveform: a statistical formulation and analysis, Am J Physiol, 285, R664
  28. Faria, 1989, Half-time of endogenous growth hormone (GH) disappearance in normal man after stimulation of GH secretion by GH-releasing hormone and suppression with somatostatin., J Clin Endocrinol Metab, 68, 535, 10.1210/jcem-68-3-535 · DOI · Paper page
  29. Petersenn, 2001, Genomic structure and transcriptional regulation of the human growth hormone secretagogue receptor., Endocrinology, 142, 2649, 10.1210/endo.142.6.8184 · DOI · Paper page
  30. Djordjijevic, 1998, Effect of 17β-estradiol on somatostatin receptor expression and inhibitory effects on growth hormone and prolactin release in rat pituitary cell cultures., Endocrinology, 139, 2272, 10.1210/endo.139.5.5990 · DOI
  31. Childs, 2005, Bipotential effects of estrogen on growth hormone synthesis and storage in vitro., Endocrinology, 146, 1780, 10.1210/en.2004-1111 · DOI
  32. Scanlan, 2003, Somatostatin-14 neurons in the ovine hypothalamus: colocalization with estrogen receptor α and somatostatin-28(1–12) immunoreactivity, and activation in response to estradiol., Biol Reprod, 69, 1318, 10.1095/biolreprod.103.017848 · DOI
  33. Bouyer, 2006, Sexually dimorphic distribution of SST2A receptors on GHRH neurons in mice., Endocrinology, 147, 2670, 10.1210/en.2005-1462 · DOI
  34. Clegg, 2007, Estradiol-dependent decrease in the orexigenic potency of ghrelin in female rats., Diabetes, 56, 1051, 10.2337/db06-0015 · DOI · Paper page
  35. De Marinis, 2000, Inhibitory action on GHRH-induced GH secretion of chronic tamoxifen treatment in breast cancer., Clin Endocrinol (Oxf), 52, 681, 10.1046/j.1365-2265.2000.00991.x · DOI
  36. Corsello, 1998, Effect of acute and chronic administration of tamoxifen on GH response to GHRH and on IGF-I serum levels in women with breast cancer., Eur J Endocrinol, 139, 309, 10.1530/eje.0.1390309 · DOI
  37. Veldhuis, 2007, Peripheral estrogen receptor-α selectively modulates the waveform of GH secretory bursts in healthy women, Am J Physiol Regul Integr Comp Physiol, 293, R1514, 10.1152/ajpregu.00438.2007 · DOI
  38. Cho, 2002, Structure and dynamics of the fusion pores in live GH-secreting cells revealed using atomic force microscopy., Endocrinology, 143, 1144, 10.1210/endo.143.3.8773 · DOI
  39. Lam, 1996, Gene expression of the receptor for growth-hormone-releasing hormone is physiologically regulated by glucocorticoids and estrogen., Neuroendocrinology, 63, 475, 10.1159/000127075 · DOI · Paper page
  40. Tena-Sempere, 2001, Neonatal imprinting and regulation of estrogen receptor α and β mRNA expression by estrogen in the pituitary and hypothalamus of the male rat., Neuroendocrinology, 73, 12, 10.1159/000054616 · DOI · Paper page
  41. Aguilar, 1992, 5α-Androstanediol stimulates the pituitary growth hormone responsiveness to growth hormone releasing hormone more effectively than testosterone or dihydrotestosterone in rats., Acta Endocrinol (Copenh), 126, 162, 10.1530/acta.0.1260162 · doi:10.1530/acta.0.1260162
  42. Orrego, 2004, Physiological testosterone replenishment in healthy elderly men does not normalize pituitary growth hormone output: evidence against the connection between senile hypogonadism and somatopause., J Clin Endocrinol Metab, 89, 3255, 10.1210/jc.2003-031530 · DOI
  43. Bondanelli, 2003, Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone-releasing hormone., Neuroendocrinology, 77, 380, 10.1159/000071310 · DOI · Paper page
  44. Liu, 1987, Chronic sex steroid exposure increases mean plasma growth hormone concentration and pulse amplitude in men with isolated hypogonadotropic hypogonadism., J Clin Endocrinol Metab, 64, 651, 10.1210/jcem-64-4-651 · DOI · Paper page
  45. Veldhuis, 2004, Short-term testosterone supplementation relieves growth hormone autonegative feedback in men., J Clin Endocrinol Metab, 89, 1285, 10.1210/jc.2003-031017 · DOI

Cited by

See all 42

Metadata

Authors
Veldhuis, J. D., Mielke, K. L., Cosma, M., Soares-Welch, C., Paulo, R., Miles, J. M., & Bowers, C. Y.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2009-03-01
Volume
94
Issue
3
Pages
973-981
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2143985871
Cited by
42
References
17
FWCI
2.40
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Aromatase and 5α-Reductase Inhibition during an Exogenous Testosterone Clamp Unveils Selective Sex Steroid Modulation of Somatostatin and Growth Hormone Secretagogue Actions in Healthy Older Men. https://app.cochat.ai/papers/10.1210/jc.2008-2108
The paper
Veldhuis, J. D., Mielke, K. L., Cosma, M., Soares-Welch, C., Paulo, R., Miles, J. M., & Bowers, C. Y. (2009). Aromatase and 5α-Reductase Inhibition during an Exogenous Testosterone Clamp Unveils Selective Sex Steroid Modulation of Somatostatin and Growth Hormone Secretagogue Actions in Healthy Older Men. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2008-2108

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.